Interferon gamma (IFN-c) and leukemia inhibitory factor (LIF) are key gestational factors that may differentially affect leukocyte function during gestation. Because IFN-c induces a pro-inflammatory phenotype in macrophages and because trophoblast cells are principal targets of LIF in the placenta, we investigated whether and how soluble factors from trophoblast cells regulate the effects of IFN-c on macrophage activation. IFN-c reduces macrophage motility, but enhances Stat1 activation, pro-inflammatory gene expression and cytotoxic functions. Soluble factors from villous cytotrophoblasts (vCT1LIF cells) and BeWo cells (BW/ST1LIF cells) that were differentiated in the presence of LIF inhibit macrophage Stat1 activation but inversely sustain Stat3 activation in response to IFN-c. vCT1LIF cells produce soluble factors that induce Stat3 activation; this effect is partially abrogated in the presence of neutralizing anti-interleukin 10 (IL-10) antibodies. Moreover, soluble factors from BW/ST1LIF cells reduce cell proliferation but enhance the migratory responses of monocytes. In addition, these factors reverse the inhibitory effect of IFN-c on monocyte/macrophage motility. BW/ST1LIF cells also generate IFN-c-activated macrophages with enhanced IL-10 expression, but reduced tumor-necrosis factor alpha (TNF-a), CD14 and CD40 expression as well as impaired cytotoxic function. Additional assays performed in the presence of neutralizing anti-IL-10 antibodies and exogenous IL-10 demonstrate that reduced macrophage cytotoxicity and proliferation, but increased cell motility result from the ability of trophoblast IL-10 to sustain Stat3 activation and suppress IFN-c-induced Stat1 activation. These in vitro studies are the first to describe the regulatory role of the LIF-trophoblast-IL-10 axis in the process of macrophage activation in response to pro-inflammatory cytokines.
INTRODUCTION
Tissue macrophages (Mws) are of interest not only to the field of immunology as part of the innate immune system, but also to other fields because they perform various homeostatic functions that are associated with tissue organization during organogenesis and in mature tissues. 1, 2 During the inflammatory response, tissue Mws are expected to sequentially develop into three different subpopulations: type-1 (Mw-1), type-2 (Mw-2) and regulatory (Reg-Mws). [3] [4] [5] [6] During the initiation phase of inflammation, the pro-inflammatory Mw-1 subtype is generated in response to two signals (i.e., Interferon gamma (IFN-c) and tumor-necrosis factor alpha (TNF-a)) or a Toll-like receptor (TLR) ligand, such as lipopolysaccharide (LPS). During the resolution phase of inflammation, the presence of the type-2 cytokines interleukin 4 (IL-4) and IL-13 leads to the generation of anti-inflammatory Mw-2, which are associated with the coordination of tissue repair. The 1 third subtype (i.e., Reg-Mws) is fundamentally different from Mw-1 and Mw-2, and the generation of this subtype requires two signals. [3] [4] [5] [6] The first signal may include IL-10, prostaglandins, immune complexes, adenine nucleotides, glucocorticoids and apoptotic cells, and the second signal is TLR activation. RegMws overproduce IL-10 but not IL-12 and exhibit potent immunosuppressive activity for modulating the acute inflammatory response and limiting tissue damage. [3] [4] [5] [6] Tissue Mws constitute one of the most abundant populations of inflammatory cells in the uterus, and the numbers of these cells remain relatively constant in the decidua throughout gestation. 7, 8 In normal pregnancies, the phenotype of uterine Mws is locally modified to acquire a type-2 phenotype, [9] [10] [11] which may contribute to trophoblast differentiation, support embryo implantation and supply growth factors to the placenta. 7, 8 However, although Mws play important roles at the maternal2fetal interface, aberrant activation of inflammatory pathways in Mws can affect trophoblast survival and function, 12 potentially leading to pregnancy complications, such as recurrent spontaneous abortion, pre-eclampsia, fetal growth restriction and intrauterine infection-associated preterm labor in humans. 7, 8 Whereas gestation has long been recognized as an antiinflammatory Th2 condition, recent studies demonstrated that the process of blastocyst implantation requires a pro-inflammatory Th1 environment. 13, 14 The transitory maintenance of this Th1 environment appears to be essential for the growth and survival of trophoblast cells, which in turn produce a balance of pro-and anti-inflammatory cytokines that are linked to the control of leukocyte recruitment, to the regulation of inflammatory activity, and to the promotion of Th2 immune responses. 14 Among the numerous cytokines produced at the implantation site, IFN-c and TNF-a are potent inducers of the pro-inflammatory type-1 phenotype in tissue Mws; 15 in the context of the developing embryo, these cytokines have both beneficial and harmful attributes. 16 Through the activation of the transcription factor signal transducer and activator of transcription 1 (Stat1), IFN-c is known to induce the expression of several pro-inflammatory genes in Mws, such as the cell death-inducing cytokine TNF-a and the cell surface receptor clusters of differentiation 14 and 40 (CD14 and CD40). 15 During early pregnancy, uterine natural killer (uNK) cells secrete IFN-c, which plays critical roles in the initiation of endometrial vasculature remodeling, in the process of angiogenesis at implantation sites, and in the maintenance of decidual and placental tissues. 16 On the other hand, inflammatory stress in pregnant mice induces higher levels of IFN-c and TNF-a synthesis by uNK cells and Mws, respectively; these cytokines in turn target uterine endothelial cells to provoke vascular damage and placental ischemia. 17, 18 For instance, gestational complications have been linked to elevated IFN-c and/or TNF-a expression in the immune-mediated, early abortion mouse model CBA/J3DBA/2J 17, 18 and in the preterm labor and delivery model that employs LPS-treated IL-10 knockout (KO) mice. 19, 20 Moreover, as observed during recurrent spontaneous abortion and intrauterine infection-associated preterm labor in humans, 7, 8 aberrant inflammatory behavior in Mws is associated with spontaneous and endotoxin-mediated abortion in rodents. 21 Thus, even if a pro-inflammatory Th1 environment appears to be required for successful blastocyst implantation, 13 ,14 the regulation of pro-inflammatory Mw activation within the pregnant uterus may be vital to the avoidance of detrimental Mw functions, which could ultimately lead to placental and fetal demise. Embryonic trophoblast cells have been proposed to participate intensively in this process by producing factors that modulate leukocyte function. 22 Recently, Mor et al. 14 proposed the theory that trophoblast/immune cell interaction involves three stages. During the attraction step, trophoblast cells secrete chemokines that can recruit immune cells to the implantation site; during the education step, trophoblast cells produce regulatory cytokines that modulate the differentiation process of immune cells; and finally, in the response step, immune cells acquire a trophoblast-supporting phenotype in response to signals from the local microenvironment.
14 However, the molecular mechanism by which uterine Mws are programmed to adopt a Th2 phenotype in response to trophoblast-derived factors remains elusive.
Many potential Mw programming factors have been described in the pregnant human uterus. 23, 24 One factor of interest is the pleiotropic cytokine leukemia inhibitory factor (LIF). LIF plays an important role in the establishment of pregnancy by supporting decidual and placental differentiation and by influencing reproductive tract cells, such as leukocytes and luminal/glandular epithelial cells. 25 The best evidence that LIF may play a role in the regulation of Mws comes from data obtained from LIF KO mice, which present a more than half reduced percentage of uterine Mws by days 3-5 of pregnancy. 25 The LIF KO mouse model also revealed the central regulatory role of LIF in endotoxic shock and host defense. Essentially, LIF expression following endotoxic shock enhances the expression of hepatic acute-phase proteins and IL-10, which downregulates TNF-a synthesis and release in the liver, conferring protection against endotoxemia. 26 In the uterus of pregnant mice, LIF likely plays a similar but local role in the protective effect of progesterone against endotoxin-induced fetal demise by reducing nitric oxide levels in utero.
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Another important gestational factor is IL-10, which is a type-2 cytokine that is expected to play a key role in pregnancy immunotolerance through the establishment of a Th2 immune response at the maternal2fetal interface. 28, 29 IL-10 inhibits the production of several pro-inflammatory cytokines, including TNF-a in Mws and IFN-c in NK cells, thereby preventing the development of type-1 immune reactions that are deleterious for both the establishment and maintenance of pregnancy. [30] [31] [32] Thus, using the IL-10 KO mice model to study LPS-induced preterm parturition, Murphy et al. 19, 20 demonstrated that in the absence of IL-10, IFN-c-producing uNK cells may exert cytotoxic functions through TNF-a production and invasiveness into the placental zone, leading to fetal demise or intrauterine fetal growth restriction. 19, 20 Moreover, IL-10 is noted for its abilities to inhibit Mw proliferation by activating Stat3 33 and In the pregnant human uterus, IL-10 is produced in large amounts by both the syncytiotrophoblast and the decidual Mws, 9, 10, 28, 29 while LIF is highly expressed by decidual Mws and uNK cells. 35 On the other hand, the IL-10 receptor is constitutively expressed on placental trophoblasts 28, 29 and decidual Mws are known to be highly responsive to IL-10.
9,10 In contrast, the expression level of LIF receptors is significantly higher in both villous and extravillous trophoblasts than in the decidua, 35 suggesting that all cells of the trophoblast lineage are major targets for the action of LIF in the placenta. However, the possible interplay between LIF, trophoblast cells and IL-10 in the modulation of Mw functional phenotypes has never been investigated. Using in vitro Mw and trophoblast differentiation models that were previously established in our lab, [36] [37] [38] [39] [40] [41] we investigate whether and how syncytiotrophoblast-derived factors in general and IL-10 in particular regulate the effects of IFN-c on the behavior of Mws in response to LIF stimulation and describe the mechanism of action of these factors at the molecular level.
MATERIALS AND METHODS

Reagents and chemicals
All cell culture media, serum and reagents were purchased from Wisent (St-Bruno, PQ, CAN). Boyden chambers, cell culture plates and flasks were from Corning (Corning, NY, USA). The cytokines LIF, IL-10 and IFN-c were purchased from Peprotech (Rocky Hill, NJ, USA). The neutralizing polyclonal anti-human IL-10 antibody (#IC2172F) was purchased from R&D Systems (Minneapolis, MN, USA). The chemicals methylthiazolyldiphenyl-tetrazolium bromide (MTT), dimethyl sulfoxide (DMSO), forskolin (FK), propidium iodide (PI) dye and all electrophoresis grade chemicals were purchased from Sigma Chemical Company (Oakville, ON, CAN). Trizol reagent and PCR primers were purchased from Invitrogen (Carlsbad, CA, USA). Taq DNA polymerase and M-MLV reverse transcriptase were purchased from New England Biolabs (Whitby, ON, USA). Cocktails of proteases and phosphatase inhibitors were purchased from Roche Applied Science (Quebec, PQ, Canada). The specific inhibitors of Stat1 (i.e., JAK inhibitor I) and Stat3 (i.e., Stat3 inhibitor V) were purchased from Calbiochem (San Diego, CA, USA). The rabbit polyclonal antibodies (Abs) against phospho (p) Stat1 (pY701), Stat1, pStat3 (pY705) and Stat3 were purchased from Cell Signaling Technologies (Pickering, ON, CAN) . The monoclonal peroxidase-conjugated mouse anti-b-actin antibody was purchased from Sigma Chemical Company, and the horseradish peroxidase-conjugated goat anti-rabbit IgG was purchased from Bio-Rad Laboratories (Mississauga, ON, CAN).
Isolation and purification of term villous cytotrophoblasts
This study was approved by the ethical committee of CHUMSt-Luc Hospital (Montreal, QC, Canada). Human term placentas (i.e., 37-41 weeks) were obtained immediately after spontaneous vaginal deliveries from uncomplicated pregnancies. Immediately after delivery, the placentas were immersed in DMEM-HG containing antibiotics (i.e., 5 mg/ml of amphotericin, 50 mg/ml of gentamycin and 0.12 mg/ml of penicillin), maintained at 4 uC and processed within 1 h. Villous cytotrophoblasts (vCTs) were isolated and purified as previously described by our group, using the trypsin-DNase/Percoll method. [39] [40] [41] Mononuclear vCTs were purified via immunomagnetic labelling using an autoMACS Myltenyi Biotec (Auburn, CA, USA) and an anti-HLA-ABC antibody, as described previously. 39 The purity of the immunopurified vCTs was determined via flow cytometry using a FITC-conjugated monoclonal antibody against cytokeratin-7. All vCT preparations used in this study were at least 98% pure after cell sorting. The vCTs were centrifuged, suspended in 37 uC culture medium, which consisted of DMEM-High Glucose medium supplemented with 2 mM Lglutamine, 25 mM 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES), 5% fetal bovine serum (FBS) and a 13 penicillin-streptomycin-neomycin antibiotic mixture, and seeded at a density of 4.5310 6 cells/well in CellBIND six-well microplates. After seeding, the cells were cultured for 12 h at 37 uC in a humidified atmosphere with 5% CO 2 , the medium was removed gently, and the cells were washed twice with prewarmed medium. Twenty-four hours later, the cells were treated with pre-warmed medium containing 50 ng/ml of human LIF and subsequently cultured for a maximum of 48 h.
39-41
Villous cytotrophoblast-like BeWo cell differentiation The BeWo human placental choriocarcinoma cell line (ATCC number CCL-98) was cultured in RPMI-1640 cell culture medium supplemented with 10% heat-inactivated FBS, 1 mM sodium pyruvate, 10 mM HEPES and 50 mg/ml of gentamicin (referred to as 10% FBS-RPMI medium). The human BeWo cell line is the most extensively used in vitro cellular model for studying villous cytotrophoblast fusion and function. 42 Undifferentiated BeWo cells are morphologically similar to primary cultures of mononuclear cytotrophoblast cells, 43 with a low spontaneous fusion rate that can be boosted upon treatment with forskolin (FK). 44 As we described previously, FK-stimulated BeWo cells also express markers of typical syncytiotrophoblast cells, such as human chorionic gonadotrophin and markedly reduced E-cadherin expression. 38 Moreover, BeWo cells express IL-10 at the mRNA and the protein levels 45, 46 and a recent study demonstrated that this cell line responds very well to exogenous IL-10. 47 Thus, these similarities to trophoblast cells support the use of BeWo cells as a valid and suitable model for studying different aspects of villous cytotrophoblast differentiation and function. In this study, to induce cytotrophoblast differentiation into syncytiotrophoblasts (ST), 10 mM FK was added to BeWo cell cultures (BW/ST), as previously described. 38 Trophoblast conditioned medium collection To obtain control medium (CTLm), fresh 10% FBS-RPMI medium was placed in the cell incubator for 48 h. Conditioned medium (CM) was prepared from primary cultures of villous cytotrophoblasts (vCTs) and BW/ST cells that were cultured for 48 h in 5% FBS-RPMI medium in the absence (i.e., CM vCT2LIF and CM BW/ST2LIF) or the presence of 50 ng/ml of LIF (i.e., CM vCT1LIF and CM BW/ST1LIF). CTLm and CM (5 ml) were centrifuged once at 250g for 5 min to eliminate cells and cell debris and were then centrifuged in a centrifugal device with a molecular weight cutoff of 3 kDa (Pall Life Science; Port Washington, NY, USA) at 3200g for 45 min to separate proteins from low molecular weight molecules, including residual FK and LIF. The concentrated proteins were diluted with an equal volume of 10% FBS-RPMI medium. Sterile cellfree CTLm and CM were snap-frozen, stored at 280 uC, and thawed on ice when required.
Monocyte and macrophage differentiation
Human subjects provided written informed consent for blood donation at the hemato-oncologic service of the Centre Hospitalier Régional de Trois-Rivières (Trois-Rivières, PQ, Canada), as approved by the Institutional Review Board of Centre Hospitalier Régional de Trois-Rivières. Over a period of 1 year, 35 voluntary blood donors were enrolled in this study. The mean age was 41.567.8 years, and the number of male donors (69%) was much higher than the number of female donors (31%). Most of the blood donors in the current study (91%) were both non-smokers and non-alcoholics. The exclusion criteria included a history of chronic immunosuppression, anti-inflammatory use and a history of hepatitis B infection. Blood monocytes were isolated as previously described. 36 Adherent mononuclear cells were recovered using Lymphocyte Separation Medium (Wisent; St-Bruno, PQ, CAN) and cultured for 5 days with 10 ng/ml of GM-CSF to induce Mw differentiation. On day 1, the purity of the monocyte-derived Mws (MDMw) was approximately 98%, as assessed via the detection of CD14 by flow cytometry. 36 The THP1 human monocytic leukemia cell line (ATCC number TIB-202) was cultured in 10% FBS-RPMI medium. The THP1 cell line is one of the most widely used cell lines for investigations of the function and differentiation of monocytes and Mws in response to various inflammatory mediators, such as IFN-c and bacterial LPS. [48] [49] [50] Undifferentiated THP1 cells resemble primary monocytes/Mws isolated from healthy donors or donors with inflammatory diseases, such as diabetes mellitus and atherosclerosis. 50 After treatment with phorbol esters, THP1 cells differentiate into macrophage-like cells, which mimic native monocyte-derived Mws in several respects. 49, 51 Because of these characteristics, the THP-1 cell line was broadly proposed as a valuable model for studying the regulation of Mw-specific genes, 51 the mechanisms involved in Mw differentiation 48 and the molecular mechanisms in monocytes and Mws that are associated with the physiology and pathophysiology of inflammatory responses. 50 In this study, green fluorescent protein (GFP)-expressing-THP1 cells were cultured for 18 h in 50 nM phorbol 12-myristate 13-acetate to induce monocyte-to-Mw differentiation. To investigate whether trophoblast-derived factors regulate the effects of IFN-c on the behavior of Mws, MDMws and GFP-THP1-derived Mws (TDMws) were cultured in the absence of cytokines to obtain control cells (Mws) or in the presence of 50 U/ml of IFN-c to induce a pro-inflammatory type-1 phenotype (Mw1IFN-c).
Migratory/chemotactic assay Undifferentiated GFP-THP1 cells were used to investigate whether trophoblast cells are able to regulate the chemotactic responsiveness of monocytes (Mo) to trophoblast-derived factors. The transwell migratory assay was conducted in a modified Boyden chamber with membrane inserts with an 8-mm pore size, as described previously. 36, 37 Briefly, GFP-THP1 cells were cultured for 24 h in the presence or absence of 50 U/ml of IFN-c and subsequently washed, counted, and seeded into the upper well of the chamber at a density of 50310 3 cells/100 ml. Meanwhile, 50310
3 BW/ST cells that were previously stimulated with a phosphate-buffered saline solution (BW/ST2LIF) or LIF (BW/ST1LIF) were seeded in the lower well. The GFP-THP1 cells that migrated down to the lower well in response to trophoblast-derived chemotactic factors were visualized using fluorescence microscopy and counted from images captured at t50 h and t548 h. All observations were made at 35 magnification using cell monolayers. Five fields were selected randomly for each treatment.
Motility assay
The in vitro scratch wound healing assay was performed to study the effects of trophoblast-derived factors on Mw cell migration. 52 Briefly, MDMws (300310 3 cells/ml) and TDMws (750310 3 cells/ml) were seeded into 24-well tissue culture plates to achieve a monolayer with about 70%-80% confluence. The cell monolayers were scraped with a p200 pipet tip in a straight line in one direction to create a 'scratch'. To obtain the same field during image acquisition, another straight line was scratched perpendicular to the first wound line to create a cross in each well. The debris was removed, and the edge of the scratch was smoothed by washing the cells once with 1 ml of Hank's buffer. The cells were then cultured in CTLm, CM BW/ST2LIF or CM BW/ST1LIF in the presence or absence of 50 U/ml of IFN-c for the in vitro scratch assay. To assess the effects of exogenous IL-10, TDMws were pre-treated for 3 h with 25 ng/ml of IL-10 and subsequently washed and activated with 50 U/ml of IFN-c. Using the cross as a reference point, the plate was placed under an inverted fluorescence microscope and images of the scratch were acquired at t50 h and t548 h. The number of motile cells was determined using the Java-based image processing program ImageJ (National Institutes of Health; Bethesda, MD, USA), and the relative cell motility was expressed as a ratio of motile cells at t548 h/t50 h within the initial wound. To study the impact of inhibiting IFN-c-induced signaling pathway activation during the healing of the wound, Mws were plated as described above. After the scratch cross line was created, the cell monolayers were treated for 60 min with either vehicle (i.e., 0.1% DMSO) or an optimal dose of the chemical inhibitors JAK inhibitor I (JAK Inh I) (i.e., 10 mM) and Stat3 inhibitor V (Stat3 Inh V) (i.e., 5 mM) before incubation with CTLm, CM DMSO, CM FK or CM FK1LIF in the presence or absence of 50 U/ml of IFN-c. To determine the influence of JAK Inh I and Stat3 Inh V on IFN-c-induced signaling pathway activation, pre-treated Mws were stimulated for 15 min and 30 min and cell lysates were prepared and analyzed via immunoblotting, as described previously. [36] [37] [38] Cell viability/proliferation assays To assess the effects of trophoblast-derived factors on the cell viability of monocytes and Mws, undifferentiated GFP-THP1 cells and TDMw were cultured in CTLm, CM BW/ST2LIF or CM BW/ST1LIF in the presence or absence of 50 U/ml of IFNc. Cell viability was assessed at t50 h and 48 h using MTT assays, as previously described. [36] [37] [38] To evaluate the number of dead cells, the cells were washed and stained for 15 min with 2 mg/ml of PI solution prior to analysis via flow cytometry. To estimate the influence of BW/ST cell-derived factors on the cytotoxic activity of Mws, TDMw were cultured for 24 h with CTLm, CM BW/ST2LIF or CM BW/ST1LIF in the presence or absence of 50 U/ml of IFN-c and subsequently washed and cultured for 24 h in serum-free RPMI-1640 culture medium. Undifferentiated BeWo cells were incubated with conditioned medium from these cell cultures. MTT assays and PI staining were performed at t50 h, 24 h and 48 h to evaluate the number of viable and dead cells, respectively. Each assay was performed in quadruplicate and represents three independent experiments.
Protein immunodetection
TDMws (7503103 cells/ml) were pre-treated for 24 h with CTLm, CM BW/ST2LIF or CM BW/ST1LIF or pre-treated for 3 h with exogenous IL-10 at concentrations of 5 and 25 ng/ml. The cells were then washed and activated with 50 U/ml of IFN-c at t50 min, 15 min and 30 min. Cell lysates were prepared and analyzed by immunoblotting, as described previously. [36] [37] [38] Briefly, protein samples were resolved by SDS-PAGE under reducing conditions and transferred onto a polyvinylidene fluoride (PVDF) membrane. The blots were first probed with rabbit polyclonal antibodies against pStat1 and pStat3 (both at dilutions of 1 : 2000) overnight at 4 uC. The blots were then incubated with a horseradish peroxidase-conjugated goat anti-rabbit IgG Ab at a dilution of 1 : 3000 for 1 h at room temperature. The same blots were stripped and then probed with anti-Stat1 and anti-Stat3 Abs, which were both used at dilutions of 1 : 1000. In both cases, the probed molecules were visualized using an enhanced chemiluminescence detection kit (Thermo Fisher Scientific; Waltham, MA, USA).
RNA isolation and reverse transcriptase polymerase chain reaction (RT-PCR) analyses
Total RNA extraction, preparation of first-strand cDNA by RT PCR were performed as previously described by our group. 36, 37 The PCR reaction conditions were chosen to ensure that the amplification of mRNA occurred in the middle of the exponential amplification phase to avoid mRNA amplification close to plateau and saturation. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA expression was used as an internal standard. The sequences of the primers used for amplification were 59-GTCAGTGGTGGACCTGACCT-39 (sense (S)) and 59-TGAGCTTGACAAAGTGGTCG-39 (antisense (AS)) for G-APDH; 59-CAGAGGGAAGAGTTCCCCAG-39 (S) and 59-CC-TTGGTCTGGTAGGAGACG-39 (AS) for TNF-a; and 59-TG-AGAACCAAGACCCAGACA-39 (S) and 59-TCATGGCTTT-GTAGATGCCT-39 (AS) for IL-10.
Surface antigen expression analysis
To study membrane receptor expression, Mws were pre-treated for 24 h with CM from BW/ST cell cultures and collected after a 48-hour stimulation period in the presence or absence of 50 U/ ml of IFN-c. The expression levels of CD14 and CD40 were evaluated by flow cytometry, as described previously. 36, 37 IL-10 neutralization assays To determine the potential involvement of trophoblast-derived IL-10 as a deactivating mediator of Mw behavior, we used a polyclonal antibody directed against IL-10 (#IC2172F; R&D System; Minneapolis, MN, USA) to neutralize IL-10 in trophoblast CM. Western blot analysis, MTT assays and in vitro scratch wound healing assays were performed as described above. Neutralizing anti-IL-10 or isotype control antibodies, which were both used at concentrations of 2 mg/ml, were added daily to Mw monolayers. A representative result from three independent experiments is shown.
Statistical analyses
For all experiments, the values were presented as the mean6s.d. from three independent experiments. The data were analyzed using one-way analysis of variance (ANOVA) followed by the Bonferonni post-test using Prism software, version 3.03 (GraphPad, San Diego, CA, USA). P values f0.05 were considered to indicate statistical significance.
RESULTS
Villous cytotrophoblast-derived factors repress Stat1 activation but inversely sustain Stat3 activation in IFN-c-activated Mws
This set of experiments was planned to investigate whether primary cultures of vCTs are responsive to LIF and whether LIF-differentiated vCTs have the ability to regulate the effects of IFN-c on the behavior of MDMws. As shown in Figure 1a , the activation of the Stat3 signaling pathway was efficiently induced in vCTs; this effect was maintained at similar levels during 15 min and 30 min of LIF stimulation. Figure 1b shows the representative activation status of Stat1 and Stat3 following stimulation with IFN-c in MDMws preconditioned for 24 h with CTLm, CM vCT2LIF, CM vCT1LIF and recombinant human LIF (rLIF). MDMws express low basal levels of pStat1 and pStat3 (t50 min) when preconditioned in CTLm, in CM vCT2LIF, in CM vCT1LIF and in the presence of rLIF (Figure 1b) . Very little or no variation in total Stat1 and Stat3 expression was observed, irrespective of treatment. As expected, IFN-c activates Stat1, with pStat1 levels increasing by 4.3-fold in the presence of CTLm at t515 min and by 7.6-fold at t530 min (Figure 1b) . These increases in pStat1 levels were efficiently reduced when MDMws were preconditioned with both CM vCT1LIF (1.9-fold at t515 min and 2.8-fold at t530 min) and rLIF (no change at t515 min and 2.1-fold at t530 min) but not with CM vCT2LIF (Figure 1b) . In contrast to pStat1, the induction of pStat3 was significantly enhanced by IFN-c only at t515 min when MDMws were preconditioned with CM vCT2LIF (4-fold), CM vCT1LIF (4.5-fold) and rLIF (2.8-fold). The ratio of phosphorylated/unphosphorylated proteins was calculated using densitometric analysis of each sample to evaluate the relative activation of pStat1 or pStat3. Different superscripts denote significant differences between treatments (P,0.05). CM, conditioned medium; CTLm, control medium; IFN-c, interferon gamma; LIF, leukemia inhibitory factor; vCT, villous cytotrophoblast; rLIF, recombinant human LIF; Stat1, signal transducer and activator of transcription 1. For the remaining studies, we opted to use a BeWo cell model due to its relevance and particularly due to its availability and reproducibility when used at early cell culture passages. 38 IL-10 mRNA expression was studied using RT-PCR to validate the use of BeWo cells as a pertinent model for studying the influence of villous cytotrophoblast-derived factors, such as IL-10, on the functional phenotype of pro-inflammatory Mws. As expected, 28, 29 undifferentiated BeWo cells express basal levels of IL-10 mRNA. However, we found that the IL-10/GAPDH ratio substantially increased from 0.260.1 to 0.760. 
Syncytiotrophoblast-derived factors affect cell proliferation but enhance the migratory response of IFN-c-activated monocytes/Mws
To determine the influence of ST-derived factors on cell proliferation, monocytes and Mws were incubated for 48 h in CTLm, CM BW/ST2LIF or CM BW/ST1LIF in the presence of 50 U/ml IFN-c and MTT viability/proliferation assays were then performed. As seen in Figure 3a , the rates of proliferation are considerably higher in IFN-c-activated monocytes (closed square; relative cell viability50.0982t10.05; R In this set of migratory/chemotactic assays, undifferentiated GFP-THP1 cells were used to investigate whether BW/ST cells effectively regulate the chemotactic responsiveness of monocytes to LIF. To achieve this aim, monocytes were first cultured for 48 h in the presence and absence of IFN-c and subsequently placed in the upper well of transwell migratory chambers. As shown in Figure 3b A set of wound healing assays was designed to investigate whether BW/ST factors also change the relative numbers of motile cells in Mw cultures pre-treated with CTLm, CM BW/ ST2LIF or CM BW/ST1LIF in the presence or absence of 50 U/ml of IFN-c. IFN-c stimulation is known to be associated with reduced chemotactic responsiveness and motility in human monocytes/Mws via the selective inhibition of the expression of CCR2, which is the receptor for the chemoattractant CCL2, which was formerly known as macrophage chemoattractant protein 1 or MCP1. 53 As expected, MDMws are motile in the absence of IFN-c. However, after a 48-hour cell culture period, the cell motility of MDMws gradually increased in response to CM BW/ST2LIF and CM BW/ST1LIF (Figure 3c ). The relative number of motile cells, which was expressed as a ratio of motile cells at t548 h/t50 h within the initial wound, was determined to be 1261 with CTLm, 2562 with CM BW/ST2LIF and 3262 with CM BW/ ST1LIF (Figure 3c ). MDMws exhibit low motility in the presence of IFN-c (i.e., a reduction to 18% of the control). However, the percentage of motile cells within the wound 
Syncytiotrophoblast-derived factors modulate Mw proinflammatory marker expression
This set of experiments was designed to investigate Mw TNF-a and IL-10 gene expression using RT-PCR and the expression of CD14 and CD40 using flow cytometry. Consistent with the pro-inflammatory role of IFN-c, the transcript level of TNFa was gradually upregulated in Mws stimulated with IFN-c; these levels increased from 0.5960.06 to 1.3960.08 after 24 h of stimulation (Figure 5a, left panel) . The levels of TNF-a mRNA were downregulated when the Mws were pre-treated with CM BW/ST1LIF and stimulated with IFN-c (0.5660.06 versus 0.3960.04) (Figure 5a, left panel) . In contrast to TNF-a, the levels of IL-10 mRNA were upregulated when the Mws were pre-treated with CM BW/ST1LIF; the IL-10/GAPDH ratio increased from 0.2160.06 to 1.1760.12 ( Figure 5a, right panel) . Notably, this rise in IL-10 mRNA expression was maintained even after Mw activation with IFN-c, when the IL-10/GAPDH ratio increased from 0.2260.08 to 1.0060.10 ( Figure 5a, right panel) .
In response to INF-c, Mw CD14 and CD40 expression were enhanced by 2-fold and 3.5-fold, respectively (Figure 5b) . Figure 4 (a) Mws were separately preconditioned for 24 h with CTLm and CM BW/ST1LIF and subsequently pre-treated for 30 min with 0.1% DMSO, 10 mM JAK Inh I or 5 mM Stat3 Inh V prior to activation with 50 U/ml of IFN-c. The motility of the Mws was evaluated using an in vitro scratch assay and visualized using a fluorescence microscope at t50 h and t548 h. Five fields were chosen randomly for each treatment. All observations were made at 35 magnification. The results are presented as the mean6s.d. from three independent experiments. Different superscripts denote significant differences between treatments (P,0.05). (b, c) Mws were preconditioned for 24 h with CTLm or CM BW/ST1LIF and subsequently pretreated with 0.1% DMSO, 10 mM Jak Inh I or 5 mM Stat3 Inh prior to incubation with 0 and 50 U/ml of IFN-c for the indicated times. The activation status of Stat1 and Stat3 was assessed using immunoblotting studies. The superscript 'a' denotes significant differences between DMSO and inhibitor treatments (P,0.05). CM, conditioned medium; CTLm, control medium; IFN-c, interferon gamma; LIF, leukemia inhibitory factor; Mw, macrophage; Stat1, signal transducer and activator of transcription 1.
Mws were preconditioned with CM BW/ST1LIF. Further, Mw-mediated cytotoxicity was restored in the presence of neutralizing anti-IL-10 Abs (Figure 6b ). Moreover, we found that IL-10 is required for BW/ST1LIF cells to trigger sustained motility in IFN-c-activated Mws (Figure 6c ). suppress IFN-c-induced Stat1 activation while Stat3 activation is maintained (Figure 7b ).
DISCUSSION
Although IFN-c has been defined as an important gestational factor and a potent inducer of the pro-inflammatory type-1 phenotype in Mws, 15 this cytokine exhibits both beneficial and harmful attributes in the context of the developing embryo. 54 The present study demonstrates that multinucleated trophoblast cells efficiently deactivate pro-inflammatory Mw-1. For instance, Mw proliferation, inflammatory gene/protein expression, and cytotoxicity were significantly reduced when IFN-c-activated Mws were preconditioned with soluble factors from syncytiotrophoblast cells. In line with our results suggesting the involvement of IL-10 in this process, our previous studies demonstrated that IL-10 and IL-10-producing Mw-2 cells Cell motility was visualized using a fluorescence microscope at t50 h and t548 h. Different superscripts denote significant differences between treatments (P,0.05). CM, conditioned medium; CTLm, control medium; IFN-c, interferon gamma; LIF, leukemia inhibitory factor; MTT, methylthiazolyldiphenyl-tetrazolium bromide; Mw, macrophage.
inhibit Mw-1 cytotoxic activity, 36 likely by blocking the endogenous production of TNF-a, which is the most important microbicidal and tumoricidal mediator produced by IFN-cactivated Mws. 55 Several lines of evidence suggest that IL-10 is an important suppressor of active maternal immunity that may be involved in the process of acceptance of the fetal allograft. 19, 20, 28, 29 IL-10 levels increase markedly in women during early pregnancy and remain elevated up to the third trimester immediately prior to the onset of labor. Of note, compared to syncytiotrophoblasts, extravillous cytotrophoblasts are intrinsically poor in IL-10 production, 28, 29 indicating that the syncytium might indeed contribute locally to counteract the deleterious effects of pro-inflammatory cytokines during early pregnancy.
Uterine CD14
1 Mws are the most important leukocyte population in the pregnant uterus of humans and mice. These cells have potential inflammatory and antigen-presenting cell functions that could be detrimental to the fetus if the cells were over-activated in response to infection. 7, 8, 13, 14, 17, 22 CD14 is part of a cognate receptor complex, which includes TLR4 and myeloid differentiation factor 2 and is involved in Mw detection of Gram-negative bacteria via binding to the outer-wall component LPS. 56 IFN-c-primed Mws produced higher levels of pro-inflammatory cytokines and chemokines after stimulation with LPS via the upregulation of CD14, TLR4 and myeloid differentiation factor 2 expression. 57 The physiological importance of the downregulation of the expression of 62 and as we established previously, this induction is associated with enhanced cytotoxic function that triggers robust Mw-mediated destruction of tumor cells. 37 Thus, as we suggested for TNF-a and CD14, the repression of Mw CD40 expression by syncytiotrophoblast cells could be viewed as a mechanism that leads to reduced cytotoxic and costimulatory functions of IFN-c-activated Mws.
Indeed, recent studies suggested that human decidual Mws could represent a regulatory or suppressive type of tissue Mws that contribute to the development of appropriate maternal immune responses to the fetus during early pregnancy. Decidual Mws spontaneously produced high levels of IL-10.
9-11 IL-10-producing decidual Mws expressed CD14 and HLA-DR, but these cells exhibited lower levels of the costimulatory molecules CD40 and CD86 than peripheral blood monocytes from pregnant and non-pregnant women. 11 Furthermore, decidual Mws fail to differentiate into dendritic cells under the influence of IL-4 and GM-CSF. 11 Sayama et al. 63 recently demonstrated that decidual Mws are able to suppress T-cell IFN-c production. This suppression occurs via B7-H1, which is a costimulatory ligand in the B7 family that negatively modulates T-cell activity by binding to the corresponding receptor PD-1. The Fisher's group proposed that decidual Mws can also protect fetal cells (i.e., trophoblast cells) against the death-inducing activity of IFN-c-producing uterine NK cells through a transforming growth factor beta 1-dependent mechanism. 64 IFN-c-mediated activation of gene transcription occurs primarily through the transcription factor Stat1. 15 Once Stat1 is phosphorylated by Jak1 and Jak2, Stat1 homodimerizes, translocates to the nucleus, and activates the transcription of multiple genes that contain an IFN-c-activating sequence in their promoters. 65 As reported here, IFN-c signaling in Mws involves Stat1 activation, and syncytiotrophoblast-derived factors, such as IL-10, have the ability to sustain Stat3 activation but inversely repress Stat1 activation in response to IFN-c stimulation. Our results strongly suggest that these inverse effects on Stat1 and Stat3 represent a molecular mechanism that could antagonize the inhibitory effects of IFN-c on Mw motility via syncytiotrophoblast-derived factors and IL-10. In accordance with our premise, previous studies demonstrated that Stat1 and Stat1-induced gene products mediate the inhibitory effects of IFN-c on Mw migration and that this inhibitory effect is completely abrogated in Stat1-deficient Mws. 66 Moreover, these studies demonstrated that Stat3 is required to sustain Mw motility. However, Stat3 does not oppose the effects of IFN-c because this cytokine can still suppress THP1 cell migration, even if the THP1 cells express high levels of activated Stat3. 66 IL-10 can directly inhibit Stat-dependent gene expression induced by IFN-c in Mws by suppressing the tyrosine phosphorylation of Stat1. 34 Furthermore, similar to IL-10, other immunosuppressive cytokines and growth factors, such as transforming growth factor beta 1 and peroxisome proliferatoractivated receptor gamma ligands, are also known to promote Mw deactivation via the suppression of IFN-c-induced Stat1 phosphorylation and activation. 67, 68 In addition to its effect on Mw motility, we also demonstrated that IL-10 mediates the inhibitory action of syncytiotrophoblast cells on Mw proliferation. These data are consistent with a previous study that demonstrated that IL-10 inhibits Mw proliferation and that this antiproliferative signal was not associated with enhanced apoptosis. 33 Notably, based on the fact that Stat3 is the primary mediator of the effects of IL-10, the authors also demonstrated that the suppression of Mw proliferation is a Stat3-dependent event; in contrast, Mw deactivation could be mediated via a Stat3-independent pathway. 33 The finding that monocytes and Mws are poorly motile in the presence of IFN-c is in accordance with previous studies that demonstrated that IFN-c stimulation is associated with reduced chemotactic responsiveness and motility in human monocytes/ Mws via the selective and rapid inhibition of CCR2 expression. 53 For instance, CCR2 is the receptor for CCL2, which is a chemotactic chemokine that is essential for the trafficking and recruitment of monocytes/Mws to the decidua. 8, 69 The inhibition of CCR2 expression by pro-inflammatory agents such as IFN-c has been proposed to retain Mws at sites of inflammation and to act as a negative feedback loop for monocyte recruitment from the blood. 70 However, because the number of uterine Mws remains relatively constant throughout gestation, circulating blood monocytes are expected to be continuously recruited to the decidua by both stromal and trophoblast cells in response to diverse chemotactic factors. 8, 69 Moreover, Mws are expected to be motile within both the decidua and the fetal membranes, as they express higher levels of genes that promote the activation of migration. 71 One of these genes encodes the nuclear repressor protein glucocorticoid receptor DNA binding factor-1 that antagonizes the inhibitory effect of transforming growth factor beta 1 on monocyte migration. 72 In this context, our results suggest that trophoblast cells could favor the movement of monocytes and Mws via a similar mechanism, antagonizing the potential blocking effects of IFN-c on monocyte/Mw motility.
In summary, we demonstrate that trophoblast-derived factors, such as IL-10, can induce the differentiation of Mws into a trophoblast-supporting phenotype by controlling Mw migration/motility and the magnitude of the Mw-mediated immune responses that are induced by pro-inflammatory cytokines, particularly IFN-c and TNF-a. Overall, our study supports the theory that immune-modulating molecules expressed by trophoblast cells are key players in the regulation of Mw inflammatory activity and in the promotion of a regulatory/suppressive phenotype in Mws. 14 
